并肩前行 重症医学液体复苏研讨会(东区)即将在上海开幕

2019-05-24 小M MedSci原创

2019年5月31日,由武田制药主办的“重症医学液体复苏研讨会(东区)”将在上海召开。

本次“重症医学液体复苏研讨会(东区)”是武田制药主办的系列会议之一,多位重症医学领域知名专家将齐聚上海,除了带来精彩的讲座,他们还将为大家分享自己宝贵的临床经验。

近年来,重症医学取得了迅速的发展,其中,液体复苏策略始终是重症医学领域备受关注的临床问题。为了进一步推动重症医学领域的发展,2019年5月31日,“重症医学液体复苏研讨会(东区)”将在上海召开。

本次 “重症医学液体复苏研讨会(东区)”是武田制药主办的系列会议之一,多位重症医学领域知名专家将齐聚上海,除了带来精彩的讲座,他们还将为大家分享自己宝贵的临床经验。


会议特色

• 关注重症领域临床中的关键问题

本次会议将关注四个临床关键问题,分别为:“脓毒症的液体复苏策略”、“脓毒性休克液体复苏的液体选择”、“神经重症的液体复苏策略”和“烧伤患者的液体复苏策略”。

脓毒症的液体复苏策略

脓毒症是重症医学面临的重要临床问题,也是重症医学的一个难点。脓毒症患者如何进行液体复苏?本次研讨会将从“脓毒症低血容量治疗:4D和4个阶段”、“EGDT,过时了吗?”和“限制性液体复苏,解决之道?”三个方面出发,结合脓毒症最新临床现状和治疗策略为大家探索最适宜的脓毒症液体复苏策略。

脓毒性休克液体复苏的液体选择

脓毒性休克是脓毒症最严重的形式,处理必须及时有效。复苏液体是保障治疗效果的根基,怎么选择最适合的复苏液体,如何最大程度的挽救患者的生命?本次研讨会将进行详细完善的探讨,相信大家一定收获颇丰。

神经重症的液体复苏策略

神经重症患者起病急,病情发展快且危重,如不正确处理,会造成严重后果。液体复苏是神经重症管理中的一个关键步骤,如何制定神经重症的液体复苏策略?本次研讨会将为大家展现最新临床研究和分析,为大家制定神经重症患者的液体复苏策略提供帮助。

烧伤患者的液体复苏策略

烧伤组织中血浆和间质之间的胶体渗透压梯度丢失,组织血管内液体丢失和水肿形成将迅速导致休克、组织灌注不足和多器官功能障碍综合征。如何制定烧伤患者的液体复苏策略?本次研讨会将结合烧伤患者病程进展的特点,为大家分析,为大家制定烧伤患者的液体复苏策略提供参考。

• 多位权威专家倾囊相授

本次会议,我们荣幸地邀请到了复旦大学附属中山医院(上海中山医院)的诸杜明教授作为大会主席。

与会专家还有:

上海交通大学医学院附属仁济医院的皋源教授

浙江大学医学院附属第二医院的黄曼教授

中国科学技术大学附属第一医院的周敏教授

上海市交通大学医学院附属瑞金医院的张勤教授

• 提纲挈领,广开言路

各位专家在精彩的讲座之后,将解答大家提出的问题并进行讨论。

会议最后,复旦大学附属中山医院诸杜明教授将为大家做总结内容,届时各位专家将针对重症医学液体复苏中面临的一些临床问题,畅所欲言,与大家分享自己的丰富经验。


会议时间

2019年5月31日(周五)


会议地点

上海王宝和大酒店(黄浦区九州路555号)


会议日程



黄浦浪花千尘雪, 东方明珠百度春,美丽上海欢迎你!

更多精彩内容,请关注后续报道!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1994828, encodeId=60d41994828a3, content=<a href='/topic/show?id=3d51e345936' target=_blank style='color:#2F92EE;'>#研讨会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73459, encryptionId=3d51e345936, topicName=研讨会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Tue Jun 25 01:22:00 CST 2019, time=2019-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1305475, encodeId=020413054e56a, content=<a href='/topic/show?id=270342e249d' target=_blank style='color:#2F92EE;'>#复苏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42724, encryptionId=270342e249d, topicName=复苏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d01326, createdName=lizhou0204, createdTime=Sun May 26 07:22:00 CST 2019, time=2019-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1556960, encodeId=dc3e155696033, content=<a href='/topic/show?id=987a6588307' target=_blank style='color:#2F92EE;'>#液体复苏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65883, encryptionId=987a6588307, topicName=液体复苏)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07bb14837728, createdName=luoxiaog, createdTime=Sun May 26 07:22:00 CST 2019, time=2019-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1579629, encodeId=1ad215e96292c, content=<a href='/topic/show?id=1f8b9592e2d' target=_blank style='color:#2F92EE;'>#重症医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95927, encryptionId=1f8b9592e2d, topicName=重症医学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=044b16545174, createdName=ms5906905816781247, createdTime=Sun May 26 07:22:00 CST 2019, time=2019-05-26, status=1, ipAttribution=)]
    2019-06-25 kcb069
  2. [GetPortalCommentsPageByObjectIdResponse(id=1994828, encodeId=60d41994828a3, content=<a href='/topic/show?id=3d51e345936' target=_blank style='color:#2F92EE;'>#研讨会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73459, encryptionId=3d51e345936, topicName=研讨会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Tue Jun 25 01:22:00 CST 2019, time=2019-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1305475, encodeId=020413054e56a, content=<a href='/topic/show?id=270342e249d' target=_blank style='color:#2F92EE;'>#复苏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42724, encryptionId=270342e249d, topicName=复苏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d01326, createdName=lizhou0204, createdTime=Sun May 26 07:22:00 CST 2019, time=2019-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1556960, encodeId=dc3e155696033, content=<a href='/topic/show?id=987a6588307' target=_blank style='color:#2F92EE;'>#液体复苏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65883, encryptionId=987a6588307, topicName=液体复苏)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07bb14837728, createdName=luoxiaog, createdTime=Sun May 26 07:22:00 CST 2019, time=2019-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1579629, encodeId=1ad215e96292c, content=<a href='/topic/show?id=1f8b9592e2d' target=_blank style='color:#2F92EE;'>#重症医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95927, encryptionId=1f8b9592e2d, topicName=重症医学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=044b16545174, createdName=ms5906905816781247, createdTime=Sun May 26 07:22:00 CST 2019, time=2019-05-26, status=1, ipAttribution=)]
    2019-05-26 lizhou0204
  3. [GetPortalCommentsPageByObjectIdResponse(id=1994828, encodeId=60d41994828a3, content=<a href='/topic/show?id=3d51e345936' target=_blank style='color:#2F92EE;'>#研讨会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73459, encryptionId=3d51e345936, topicName=研讨会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Tue Jun 25 01:22:00 CST 2019, time=2019-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1305475, encodeId=020413054e56a, content=<a href='/topic/show?id=270342e249d' target=_blank style='color:#2F92EE;'>#复苏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42724, encryptionId=270342e249d, topicName=复苏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d01326, createdName=lizhou0204, createdTime=Sun May 26 07:22:00 CST 2019, time=2019-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1556960, encodeId=dc3e155696033, content=<a href='/topic/show?id=987a6588307' target=_blank style='color:#2F92EE;'>#液体复苏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65883, encryptionId=987a6588307, topicName=液体复苏)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07bb14837728, createdName=luoxiaog, createdTime=Sun May 26 07:22:00 CST 2019, time=2019-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1579629, encodeId=1ad215e96292c, content=<a href='/topic/show?id=1f8b9592e2d' target=_blank style='color:#2F92EE;'>#重症医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95927, encryptionId=1f8b9592e2d, topicName=重症医学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=044b16545174, createdName=ms5906905816781247, createdTime=Sun May 26 07:22:00 CST 2019, time=2019-05-26, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1994828, encodeId=60d41994828a3, content=<a href='/topic/show?id=3d51e345936' target=_blank style='color:#2F92EE;'>#研讨会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73459, encryptionId=3d51e345936, topicName=研讨会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Tue Jun 25 01:22:00 CST 2019, time=2019-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1305475, encodeId=020413054e56a, content=<a href='/topic/show?id=270342e249d' target=_blank style='color:#2F92EE;'>#复苏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42724, encryptionId=270342e249d, topicName=复苏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d01326, createdName=lizhou0204, createdTime=Sun May 26 07:22:00 CST 2019, time=2019-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1556960, encodeId=dc3e155696033, content=<a href='/topic/show?id=987a6588307' target=_blank style='color:#2F92EE;'>#液体复苏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65883, encryptionId=987a6588307, topicName=液体复苏)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07bb14837728, createdName=luoxiaog, createdTime=Sun May 26 07:22:00 CST 2019, time=2019-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1579629, encodeId=1ad215e96292c, content=<a href='/topic/show?id=1f8b9592e2d' target=_blank style='color:#2F92EE;'>#重症医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95927, encryptionId=1f8b9592e2d, topicName=重症医学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=044b16545174, createdName=ms5906905816781247, createdTime=Sun May 26 07:22:00 CST 2019, time=2019-05-26, status=1, ipAttribution=)]

相关资讯

相约首都:重症医学液体复苏研讨会重磅来袭!

重磅学术会议“重症医学液体复苏研讨会”将于2019年4月14日上午在北京召开。

“重症医学液体复苏研讨会”在京成功召开

此次重症医学液体复苏研讨会的成功召开不仅促进了液体复苏的进一步发展也必将对重症医学科的发展起到推动作用。

“重症医学液体复苏研讨会”系列会议在广州成功召开

2019年4月18日,由武田中国医学部主办的重症医学液体复苏研讨会系列会议在“美丽羊城”广州成功召开。